A major advance in cancer research is arising with the use of mini-antibodies to re-engage damaged p53. This crucial malignant inhibitor protein is frequently disabled in many forms of cancer, causing uncontrolled https://socialwebleads.com/story7498167/nanobodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-management